With the recent changes in clinical trial regulations and the growth of clinical trials in Europe, Veristat continues to build its footprint in the European region. Veristat’s VP of Europe, Montserrat Barcélo Riera, recently spoke to Annelot Huijgen of Biotech Finances to share updates on Veristat’s growth trajectory in Europe and how
Veristat is a Massachusetts-based CRO that provides services such as regulatory consulting, medical writing, and monitoring for the pharmaceutical industry.